Key facts
- This page summarizes Magda Michna's Form 4 filing for STAAR SURGICAL CO (STAA).
- 9 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 16 Mar 2026, 17:00.
Magda Michna - 12 Mar 2026 Form 4 Insider Report for STAAR SURGICAL CO (STAA)
- Reporting relationship
- Chief Development Officer
- Issuer ticker
- STAA
- Reported as of
- 12 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Mar 2026, 17:00:14 UTC
- Prior SEC filing
- 14 May 2025
- Next SEC filing
- 12 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Magda Michna
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Magda Michna filed Form 4 for STAAR SURGICAL CO (STAA) on 16 Mar 2026.
Change
- Previous filing in this sequence was filed on 14 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001731487
Primary reporting owner
Michna Magda
- Relationship
- Chief Development Officer
- Address
- 25510 COMMERCENTRE DRIVE, LAKE FOREST
- Signature
- /s/ Magda Michna
- Signature date
- 16 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
STAA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +6,178
- Change %
- +43%
- Price
- $0.000000*
- Shares after
- 20,622
- Date
- 12 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
STAA
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -2,216
- Change %
- -11%
- Price
- $18.39*
- Shares after
- 18,406
- Date
- 12 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
STAA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +14,663
- Change %
- +80%
- Price
- $0.000000*
- Shares after
- 33,069
- Date
- 14 Mar 2026
- Ownership
- Direct
- Footnotes
- F3
STAA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,932
- Change %
- +8.9%
- Price
- $0.000000*
- Shares after
- 36,001
- Date
- 14 Mar 2026
- Ownership
- Direct
- Footnotes
- F4
STAA
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -6,313
- Change %
- -18%
- Price
- $18.84*
- Shares after
- 29,668
- Date
- 14 Mar 2026
- Ownership
- Direct
- Footnotes
- F3, F4, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
STAA
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -6,178
- Change %
- -50%
- Price
- $0.000000*
- Shares after
- 6,178
- Date
- 12 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,178
- Exercise price
- $0.000000
- Footnotes
- F1, F6
STAA
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- Shares
- +33,838
- Change %
- Price
- $0.000000*
- Shares after
- 33,838
- Date
- 13 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 33,838
- Exercise price
- $0.000000
- Footnotes
- F2, F6
STAA
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -14,663
- Change %
- -33%
- Price
- $0.000000*
- Shares after
- 29,326
- Date
- 14 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 14,663
- Exercise price
- $0.000000
- Footnotes
- F3, F6
STAA
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -2,932
- Change %
- -33%
- Price
- $0.000000*
- Shares after
- 5,866
- Date
- 14 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,932
- Exercise price
- $0.000000
- Footnotes
- F4, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, 1/3 (6,178 shares) on March 12, 2026, and will vest as to 1/3 (6,178 shares) on March 12, 2027. On March 12, 2026, 2,216 shares were witheld upon vesting to satisfy taxes.
Footnote F2
Reflects RSUs granted to the Reporting Person on March 13, 2026 in connection with annual equity award. These RSUs vest as to 1/3 (11,279 shares) on March 13, 2027, 1/3 (11,279 shares) on March 13, 2028, and 1/3 (11,280 shares) on March 13, 2029.
Footnote F3
Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (14,663 shares) on March 14, 2026, and will vest as to 1/3 (14,663 shares) on March 14, 2027, and 1/3 (14,663 shares) on March 14, 2028. On March 14, 2026, 5,261 shares were witheld upon vesting to satisfy taxes.
Footnote F4
Reflects RSUs granted to the Reporting Person on March 14, 2025. These RSUs vested as to 1/3 (2,932 shares) on March 14, 2026, and will vest as to 1/3 (2,933 shares) on March 14, 2027, and 1/3 (2,933 shares) on March 14, 2028. On March 14, 2026, 1,052 shares were witheld upon vesting to satisfy taxes.
Footnote F5
Includes previously granted RSUs, which are subject to future vesting.
Footnote F6
Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.